{
    "2020-06-19": [
        [
            {
                "time": "2021-06-07",
                "original_text": "Alzheimer's Drug Approval More Critical for Biogen After Patent Decision",
                "features": {
                    "keywords": [
                        "Alzheimer's",
                        "Drug",
                        "Approval",
                        "Biogen",
                        "Patent"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-07",
                "original_text": "Nkarta files for IPO",
                "features": {
                    "keywords": [
                        "Nkarta",
                        "IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-07",
                "original_text": "Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "FDA",
                        "Approvals",
                        "MRK",
                        "LLY",
                        "NVS",
                        "GSK"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}